The company had $15.8 million in revenues, up 5.3 percent from $15 million for the second quarter of 2004.
Research and development costs stayed flat, at $417,000, compared to $454,000 during last year's second quarter.
Orchid's net loss totaled $1.8 million, or $.07 per share, down from $2.1 million, or $.10 per share, for the year-ago period.
As of June 30, Orchid had $12.7 million in cash and cash equivalents, and $14.7 million in short-term investments.